SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Tapanes, F J
Right arrow Articles by Bianco, N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tapanes, F J
Right arrow Articles by Bianco, N
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cluster analysis of antinuclear autoantibodies in the prognosis of SLE nephropathy: are anti-extractable nuclear antibodies protective?

F J Tapanes

Centro Nacional de Enfermedades Reumiticas, Rheumatology Division, Caracas 101 OA, Venezuela; ftapanesreacciun.ve

M Vdsquez

School of Statistics; Universidad Central de Venezuela

R Ramirez

Institituto de Inmnunologia; Universidad Central de Venezuela

C Matheus

M A Rodriguez

Centro Nacional de Enfermedades Reumiticas, Ministerio de Salud y Desarrollo Social; Universidad Central de Venezuela

N Bianco

Institituto de Inmnunologia; Universidad Central de Venezuela

To investigate the possible role of anti-ENA autoantibodies in the pathogenesis of SLE nephropathy, we performed a cross sectional clustering study of 91 SLE patients using 75 clinical and laboratory variables examining the presence of anti-dsDNA and ENA autontibodies by ELISA and Western blot. We applied principal component, hierarchical cluster, multiple correspondence and logistical regression analysis. Two polar forms of SLE nephropathy and five clinical groups were identified: group 1 without overt nephropathy (n = 37), group 2 with nephropathy and only proteinuria (n = 19), group 3 nephropathy and only hematuria (n = 11), group 4 with hematuria and proteinuria (n = 14) and group 5 on renal failure (n = 10). When analyzed individually, levels of anti-dsDNA and single anti-ENA antibodies did not allow us to differentiate between renal and non-renal groups. However, when the anti-ENA autoantibodies were analyzed as a cluster, a high predictive value for clinical nephropathy was obtained. Thus, the absence of ENA antibodies (ENA ve or Venezuelan cluster) increased eleven-fold the odds ratio to develop SLE nephropathy. We suggested that the ENA ve cluster may predict development of the most severe forms of renal lupus while the ENA Sm/RNP and the ENA Ro/La/Sm/RNP clusters could be associated with the absence and the most benign form of SLE nephropathy. It must be interesting to apply similar cluster methodology in an SLE population with different ethnic background.

Key Words: anti-ENA autoantibodies • SLE nephropathy • hierarchical cluster analysis (HCA) • logistic regression model (LRM) • multiple correspondence analysis (MCA)

Lupus, Vol. 9, No. 6, 437-444 (2000)
DOI: 10.1191/096120300678828604


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
LupusHome page
M E Zabaleta-Lanz, L E Munoz, F J Tapanes, R E Vargas-Arenas, I Daboin, Y Barrios, J A Pinto, and N E Bianco
Further description of early clinically silent lupus nephritis
Lupus, December 1, 2006; 15(12): 845 - 851.
[Abstract] [PDF]


Home page
LupusHome page
S. Binder
Autoantibody Detection Using Multiplex Technologies
Lupus, July 1, 2006; 15(7): 412 - 421.
[Abstract] [PDF]


Home page
Ann Rheum DisHome page
P Alba, L Bento, M J Cuadrado, Y Karim, M F Tungekar, I Abbs, M A Khamashta, D D'Cruz, and G R V Hughes
Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis
Ann Rheum Dis, June 1, 2003; 62(6): 556 - 560.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
L. D. Heinlen, M. T. McClain, X. Kim, A. I. Q. Del-Rio, J. A. James, J. B. Harley, and R. H. Scofield
Letter to the Editor
Lupus, April 1, 2003; 12(4): 335 - 337.
[PDF]


Home page
LupusHome page
M Zabaleta-Lanz, R E Vargas-Arenas, F Tapanes, I Daboin, J A. Pinto, and N E Bianco
Silent nephritis in systemic lupus erythematosus
Lupus, January 1, 2003; 12(1): 26 - 30.
[Abstract] [PDF]



Advertisement